The Senate’s health committee convened its first hearing of the year on the efficacy of the chemical abortion drug ...
A plan to slash Food and Drug Administration drug review times is raising alarms at the public health agency that's been ...
A few recent examples of the FDA’s approach to drugs show how bad the agency’s risk aversion has become. The FDA has ...
The FDA commissioner's effort to shorten the review of drugs favored by the Trump administration is causing alarm across the ...